Phenol‐benzoxazolone bioisosteres of GluN2B‐NMDA receptor antagonists: Unexpected rearrangement during reductive alkylation with phenylcyclohexanone
Open Access
- 30 July 2022
- journal article
- research article
- Published by Wiley in Archiv der Pharmazie
- Vol. 355 (11) , e2200225
Abstract
Negative allosteric modulators of N‐methyl‐ d‐aspartate receptors containing the GluN2B subunit represent promising drug candidates for the treatment of various neurological disorders including stroke, epilepsy, and Parkinson's disease. To increase the bioavailability and GluN2B affinity, the phenol of the potent benzazepine‐based inhibitor, WMS‐1410 (3), was replaced bioisosterically by a benzoxazolone moiety and the phenylbutyl side chain was conformationally restricted in a phenylcyclohexyl substituent. A four‐step, one‐pot procedure transformed the oxazolo‐benzazepine 7 into the phenylcyclohexyl derivative 11. The same protocol was applied to the methylated analog 12, which unexpectedly led to ring‐contracted oxazolo‐isoquinolines 18. This rearrangement was explained by the additional methyl moiety in the 8‐position inhibiting the formation of the planar intermediate iminium ion with phenylcyclohexanone. The allyl protective group of 11 and 18 was removed with RhCl3 and HCl to obtain the tricyclic compounds 5 and 19 without substituent at the oxazolone ring. The structures of the rearranged products 18 and 19 were elucidated by X‐ray crystal structure analysis. The oxazolo‐isoquinoline trans‐18 with allyl moiety (Ki = 89 nM) and the oxazolo‐benzazepine 5 without substituent at the oxazolone ring (Ki = 114 nM) showed GluN2B affinity in the same range as the lead compound 3. In two‐electrode voltage clamp measurements, 5 displayed only weak inhibitory activity.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (WU 176)
This publication has 43 references indexed in Scilit:
- Influence of GluN2 subunit identity on NMDA receptor functionNeuropharmacology, 2013
- Subunit arrangement and phenylethanolamine binding in GluN1/GluN2B NMDA receptorsNature, 2011
- Development of a selective competitive receptor binding assay for the determination of the affinity to NR2B containing NMDA receptorsJournal of Pharmaceutical and Biomedical Analysis, 2010
- Conformationally constrained NR2B selective NMDA receptor antagonists derived from ifenprodil: Synthesis and biological evaluation of tetrahydro-3-benzazepine-1,7-diolsBioorganic & Medicinal Chemistry, 2010
- Glutamate Receptor Ion Channels: Structure, Regulation, and FunctionPharmacological Reviews, 2010
- Allosteric modulators of NR2B‐containing NMDA receptors: molecular mechanisms and therapeutic potentialBritish Journal of Pharmacology, 2009
- A nomenclature for ligand-gated ion channelsNeuropharmacology, 2009
- A short history of SHELXActa Crystallographica Section A Foundations of Crystallography, 2007
- [20] Processing of X-ray diffraction data collected in oscillation mode1997
- Ifenprodil inhibition of the 5-Hydroxytryptamine3 receptorNeuropharmacology, 1995